Miyako Capital

Oishii Farm is a pioneering company specializing in indoor vertical farming technology, specifically focusing on the commercial cultivation of strawberries. Founded in 2017 by Hiroki Koga and Brendan Somerville, Oishii employs innovative techniques to grow strawberries sustainably and pesticide-free throughout the year, regardless of geographical location. The company’s approach addresses important environmental challenges by significantly reducing water usage while enhancing crop yields. Oishii sells its premium strawberries in packages of eight to eleven units, priced at $50 per container, through various supermarkets. This business model allows Oishii to meet the growing demand for high-quality, locally-sourced produce.

Peds3 is a digital healthcare company focused on pediatric medicine and maternal-child health. It develops a digital platform that integrates digital technology and evidence-based medicine to deliver biopsychosocial care for children, aiming to enhance health outcomes.

Innovative Space Carrier is an aerospace company specializing in space transportation. It develops reusable space vehicles to make space travel more affordable, frequent, and reliable. The company's core business is to reduce transportation costs while maintaining high reliability, thereby fostering new industries and opportunities in space.

Sakana AI is a research-focused company dedicated to developing innovative foundation models inspired by nature. It specializes in creating an AI model capable of generating text, images, video, code, and multimedia, facilitating collaborative research and development in generative AI. The company's AI development process emphasizes evolution and collective intelligence.

Orange is a developer of a variety of deep-learning models with a focus on computer vision and natural language processing for comics.

Oishii Farm is a pioneering company specializing in indoor vertical farming technology, specifically focusing on the commercial cultivation of strawberries. Founded in 2017 by Hiroki Koga and Brendan Somerville, Oishii employs innovative techniques to grow strawberries sustainably and pesticide-free throughout the year, regardless of geographical location. The company’s approach addresses important environmental challenges by significantly reducing water usage while enhancing crop yields. Oishii sells its premium strawberries in packages of eight to eleven units, priced at $50 per container, through various supermarkets. This business model allows Oishii to meet the growing demand for high-quality, locally-sourced produce.

Esa is an environment solutions company that engages in plastic waste recycling, product creation, and distribution services.

LocationMind Co., Ltd. is a Japan-based IT company established in 2019, specializing in artificial intelligence-based software solutions for human flow analysis and location data utilization. The company offers a range of products, including LocationMind xPop, a SaaS dashboard tailored for diverse people flow analysis needs, and MobMap, a tool that enables time series analysis of human flow data. Leveraging big data and spatial information engineering, LocationMind develops advanced AI models that not only analyze past human movement but also predict future trends. The company's innovative solutions cater to various industries and institutions, providing critical insights into people's density, movement patterns, and transport modes, thus positioning LocationMind as a key player in the advancement of next-generation technology.

Sakana AI is a research-focused company dedicated to developing innovative foundation models inspired by nature. It specializes in creating an AI model capable of generating text, images, video, code, and multimedia, facilitating collaborative research and development in generative AI. The company's AI development process emphasizes evolution and collective intelligence.

Galdieria is a biotechnology company providing urban mining recycling, precious metals absorbent, cleantech, and energy-related services.

Helpfeel is a technology company focused on human empowerment through knowledge delivery. It specializes in providing tools for Frequently Asked Questions (FAQs), internal knowledge searches, and product recommendations. Its innovative platform allows users to efficiently find answers and connect ideas through collaborative work links. Helpfeel aims to enhance user experiences by streamlining access to information, making it easier for individuals and organizations to navigate their inquiries. Established with a commitment to delivering effective knowledge solutions, the company is positioned to play a significant role in improving information accessibility and user engagement.

SocialGood, Inc. is a company dedicated to creating a global platform aimed at providing financial freedom to individuals worldwide. It has developed the SocialGood App, which enables users to earn cryptocurrency rewards as they shop online. With over 2.3 million users across more than 200 countries and territories, the app collaborates with over 20,000 major shopping websites, allowing users to accumulate SocialGood cryptocurrency based on their spending. The company has also secured 68 patents in Japan, including its innovative Crypto Back system, which underpins its rewards model. Through its offerings, SocialGood, Inc. seeks to empower consumers by turning their shopping activities into valuable assets.

Viage Therapeutics is a neuroscience company established in 2018, focusing on the development of innovative neurotherapeutics. The company is dedicated to discovering and creating a new class of drugs aimed at treating psychiatric and inflammatory diseases, including conditions such as depression, anxiety, and gastrointestinal disorders. Through its groundbreaking research, Viage Therapeutics seeks to address significant unmet medical needs, providing healthcare professionals with access to novel therapeutic options that could improve patient outcomes.

VLP Therapeutics, LLC, established in 2012 and headquartered in Gaithersburg, Maryland, focuses on developing innovative medical treatments aimed at transforming traditional vaccines and targeted antibody therapies. The company leverages its proprietary next-generation i-αVLP (inserted alpha VLP) Technology to address significant global unmet medical needs. VLP Therapeutics aims to tackle pressing public health challenges of the 21st century, enabling healthcare providers to effectively treat cancer, infectious diseases, and autoimmune disorders. Through its advancements in medical treatment, the company seeks to improve patient outcomes and contribute to global health solutions.

ALGO ARTIS is a software company that specializes in optimizing various aspects of plant operations, including tanking, ship allocation planning, and logistics. By utilizing algorithmic methods and user-friendly artificial intelligence technology, ALGO ARTIS provides a consulting design system aimed at enhancing management and operational efficiency. The company's solutions facilitate the correct selection of technology and processes, allowing businesses to streamline their operations effectively. Through its innovative approach, ALGO ARTIS supports organizations in achieving improved performance and operational optimization.

VividQ Limited is a technology company based in Cambridge, United Kingdom, specializing in the development of software frameworks for generating, compressing, and transmitting 3D holographic images and video. The company offers a variety of products, including VividQ Capture, an API for converting 3D data into holographic formats, and VividQ Squeeze, a solution for compressing point cloud 3D data. Additionally, VividQ Core enables multi-user interactions with holograms at different focal planes, while VividQ View allows integration of various spatial light modulators into its holographic architecture. VividQ's advanced computational display technology aims to revolutionize digital displays by integrating holographic visuals into consumer electronics, augmented reality, virtual reality, and automotive applications. The company, which was formerly known as Penteract28 Limited before rebranding in 2017, collaborates with leading original equipment manufacturers to enhance user experiences in various sectors, including gaming, immersive simulations, and depth sensing.

Startbahn, Inc. is a Tokyo-based company founded in 2014 that operates as a platform for artists in the digital age. It focuses on providing technology and infrastructure to support the art community globally. The company has developed Startbahn Cert., a service that issues blockchain certificates for artworks, and is working on Startrail, a blockchain infrastructure that underpins this certification system. Startbahn's offerings include a certificate management system that allows users to access registration information via smartphone and a marketplace for buyers to discover artworks. Additionally, the company engages in various activities such as artwork production, art direction, consulting, and design services, contributing to the broader art ecosystem.

VLP Therapeutics, LLC, established in 2012 and headquartered in Gaithersburg, Maryland, focuses on developing innovative medical treatments aimed at transforming traditional vaccines and targeted antibody therapies. The company leverages its proprietary next-generation i-αVLP (inserted alpha VLP) Technology to address significant global unmet medical needs. VLP Therapeutics aims to tackle pressing public health challenges of the 21st century, enabling healthcare providers to effectively treat cancer, infectious diseases, and autoimmune disorders. Through its advancements in medical treatment, the company seeks to improve patient outcomes and contribute to global health solutions.

Hacarus Inc. is a technology company based in Kyoto, Japan, that specializes in artificial intelligence solutions for the manufacturing and medical sectors. Established in 2014, Hacarus develops products that leverage its proprietary Sparse Modeling technology, which allows for efficient data analysis and decision-making. The company offers several key platforms, including SALUS, which caters to medical and life sciences applications, and COLIGO, a customizable application that supports various implementations in IoT and edge computing. Additionally, Hacarus provides SPECTRO, a tool for enhanced visual inspections, and offers data science consulting services along with an AI Academy for education in AI technologies. By focusing on small data and resource-efficient solutions, Hacarus aims to deliver insights that enable faster and more reliable decision-making compared to traditional deep learning approaches.

Floadia Corporation is a Tokyo-based company established in 2011 that specializes in the development, licensing, and sale of semiconductor intellectual property, particularly focused on embedded non-volatile memory solutions. With a strong engineering team comprising former employees from Renesas, Floadia leverages extensive experience in embedded FLASH technology to deliver innovative low-power memory chips. The company's products are designed for diverse applications, including Internet of Things devices, automobiles, smartphones, and smart cards. Floadia's offerings not only reduce manufacturing costs but also enhance power efficiency and boast auto-grade heat endurance capabilities, making them suitable for a variety of demanding environments. In addition to its product portfolio, Floadia also provides technology consulting services to its clients.

Varinos Inc. is a clinical testing company based in Tokyo, Japan, founded in 2017. It specializes in genomic testing and continuous clinical sequencing services, partnering with medical institutions to provide advanced contract analysis. Utilizing next-generation sequencing technology, Varinos offers services such as endometrial microbiome testing and flow of intrauterine flora testing. The company's innovative genome analysis capabilities enable the detection of microscopic amounts of bacteria and facilitate the examination of genes and chromosomes in embryos before pregnancy, thereby assisting women in identifying potential abnormalities and reducing associated physical and mental burdens.

CellAxia Inc. is a biotechnology company based in Tokyo, Japan, specializing in the development of cell therapy drugs. Founded in 2017, the company focuses on the discovery, development, and commercialization of biological therapies aimed at treating intractable autoimmune diseases. CellAxia is dedicated to advancing research in cell therapy by enabling researchers to utilize challenging cell types, such as primary and cancer stem cell cultures, to identify and create innovative therapeutic cell-based solutions for the healthcare sector.

BizteX, Inc. is a Tokyo-based company founded in 2015 that specializes in developing cloud-based robotic process automation (RPA) solutions. The company offers its flagship service, BizteX Cobit, which utilizes artificial intelligence to automate routine tasks, allowing businesses to streamline operations and improve efficiency. By providing a digital robot that can perform repetitive functions with minimal human intervention, BizteX aims to enhance productivity and creativity within organizations. The software is designed to be user-friendly, enabling automation through a web browser, thus allowing businesses to focus their resources on more strategic activities.

Liberaware specializes in developing non-GPS small drones tailored for industrial use, with a focus on indoor confined-space inspections. The company offers IoT and AI-driven solutions to enhance the capabilities of these drones. Additionally, Liberaware provides inspection services, drone rentals and sales, as well as data processing and analysis services for the information collected by their equipment.

Goryo Chemical, Inc. is a Japanese company specializing in the development of fluorescent probes and functional dyes for applications in chemical biology and diagnostics. Founded in 2010 and headquartered in Sapporo, with an additional office in Tokyo, the company offers a range of products including AcidiFluor, CalFluor, GlycoFluor, and MetalloFluor, among others. These fluorescent probes are designed for cellular analysis, assay, and imaging, enabling selective staining of acidic organelles such as lysosomes and late endosomes. Goryo Chemical also provides bioluminescent probes, labeling services, and custom synthesis, catering to various needs in molecularly-targeted drug and immunoassay applications. The company serves its customers through a network of distributors both domestically and internationally.

Integral Geometry Science Inc. is a Japanese company founded in 2012, based in Kobe, that specializes in the design and development of advanced measurement devices and software for image data processing. The company focuses on the inverse analysis theory of electromagnetic fields and scattered fields, creating innovative solutions such as a microwave mammography system that effectively addresses the challenges of imaging high-density breast tissue. This technology provides clear images that aid healthcare professionals in accurately distinguishing between cancerous and non-cancerous tissue, significantly reducing the need for painful and radiation-exposing conventional screening methods. Additionally, Integral Geometry Science manufactures nondestructive inspection systems for lithium-ion batteries, further expanding its expertise in measurement systems.

Atomis Inc. is a manufacturer of porous coordination polymers (PCPs), which are specialized materials designed for the precise confinement of gas molecules. Founded in 2015 and headquartered in Kyoto, Japan, the company engages in the research, development, and production of these materials, which have applications in various fields including molecular separations, gas transportation, and catalysis. Atomis offers comprehensive evaluation services, including crystal structure analysis and gas adsorption assessments, to optimize the manufacturing processes of PCPs. The company's technology is rooted in research from Distinguished Professor Susumu Kitagawa at Kyoto University, and it aims to create innovative solutions that provide distinct value in energy delivery and environmental applications. Originally known as MaSaKa-NeXT Inc., the company rebranded to Atomis Inc. in April 2017.

Integral Geometry Science Inc. is a Japanese company founded in 2012, based in Kobe, that specializes in the design and development of advanced measurement devices and software for image data processing. The company focuses on the inverse analysis theory of electromagnetic fields and scattered fields, creating innovative solutions such as a microwave mammography system that effectively addresses the challenges of imaging high-density breast tissue. This technology provides clear images that aid healthcare professionals in accurately distinguishing between cancerous and non-cancerous tissue, significantly reducing the need for painful and radiation-exposing conventional screening methods. Additionally, Integral Geometry Science manufactures nondestructive inspection systems for lithium-ion batteries, further expanding its expertise in measurement systems.

StemRIM is a biotechnology company based in Ibaraki, Japan, founded in 2006, specializing in the development of regeneration-guided medicines for treating intractable diseases. The company focuses on innovative research and development of therapies that mobilize stem cells within the body to promote healing in various conditions, including epidermolysis bullosa, cerebral infarction, and myocardial infarction. StemRIM offers a range of products, including regeneration-inducing peptides and proteins, as well as therapeutic autologous cell collection devices and stem cell gene therapy technologies. The company aims to advance regenerative medicine by creating treatments that facilitate functional tissue regeneration without the need for external stem cell extraction.

Hacarus Inc. is a technology company based in Kyoto, Japan, that specializes in artificial intelligence solutions for the manufacturing and medical sectors. Established in 2014, Hacarus develops products that leverage its proprietary Sparse Modeling technology, which allows for efficient data analysis and decision-making. The company offers several key platforms, including SALUS, which caters to medical and life sciences applications, and COLIGO, a customizable application that supports various implementations in IoT and edge computing. Additionally, Hacarus provides SPECTRO, a tool for enhanced visual inspections, and offers data science consulting services along with an AI Academy for education in AI technologies. By focusing on small data and resource-efficient solutions, Hacarus aims to deliver insights that enable faster and more reliable decision-making compared to traditional deep learning approaches.

ARTham Therapeutics Inc is a biopharmaceutical company based in Naka-Ku, Japan, founded in 2018. The company focuses on delivering innovative biological medicines aimed at treating debilitating diseases. Its portfolio includes programs such as art-648, art-ep, art-pde, and art-001, which are designed to address specific medical needs in areas including inflammatory skin diseases, vascular malformations, and immuno-oncology endometriosis. Operating under a virtual research and development model, ARTham Therapeutics collaborates with academic and business partners to drive innovation and create disease-modifying therapies that enhance patient health and quality of life.

Trigence Semiconductor, Inc. is an audio integrated circuit design and solution provider based in Tokyo, Japan, with additional offices in the United States, Hong Kong, and Taiwan. Founded in 2006, the company specializes in high-quality audio technology, offering digital audio products such as Digital Speaker Modules, which include speakers, enclosures, connectors, audio DSPs, and interfaces aimed at simplifying audio functionality for PCs, tablets, and smartphones. Trigence's product portfolio serves a variety of applications, including computers, laptops, headsets, soundbars, and Bluetooth speakers. Their innovative audio systems utilize unique algorithms to enhance speaker response, delivering clear audio output while optimizing power consumption compared to traditional methods. The company distributes its products through a network of distributors, catering to both consumer and IT markets.

Megakaryon Corporation is a medical research company based in Kyoto, Japan, with an additional office in Tokyo. Founded in 2011, the company specializes in developing innovative blood products, specifically platelets and red blood cells, from human induced pluripotent stem (iPS) cell lines. Megakaryon's technology focuses on transfusion medicine, enabling the production of platelets without reliance on traditional blood donations. This approach aims to enhance clinical applications and provide medical practitioners with the ability to manage and maintain patients' platelet counts effectively.

StemRIM is a biotechnology company based in Ibaraki, Japan, founded in 2006, specializing in the development of regeneration-guided medicines for treating intractable diseases. The company focuses on innovative research and development of therapies that mobilize stem cells within the body to promote healing in various conditions, including epidermolysis bullosa, cerebral infarction, and myocardial infarction. StemRIM offers a range of products, including regeneration-inducing peptides and proteins, as well as therapeutic autologous cell collection devices and stem cell gene therapy technologies. The company aims to advance regenerative medicine by creating treatments that facilitate functional tissue regeneration without the need for external stem cell extraction.

Institution for a Global Society is a people analytics company that specializes in providing innovative assessment solutions to educational institutions and businesses. The organization focuses on the identification, recruitment, and development of human capital through its various offerings, which include GROW Academy, DxGROW, Ai GROW, and GROW360. By leveraging predictive analytics, the company serves a diverse clientele, including multinational corporations, government agencies, and international institutions. Committed to ethical technology use, Institution for a Global Society aims to foster a sustainable learning environment that supports lifelong development for individuals across various sectors.

REGiMMUNE Corporation is a biotechnology company based in Tokyo, Japan, with an additional office in San Francisco, California. Founded in 2006, the company specializes in the discovery and development of immune-regulatory therapeutics aimed at treating severe diseases and disorders related to the immune system. Utilizing its proprietary reVax technology, REGiMMUNE targets immune tolerance by inducing regulatory T cells, which can address a variety of conditions such as Graft versus Host Disease, type 1 diabetes, rheumatoid arthritis, multiple sclerosis, and systemic lupus erythematosus. The company has one clinical-stage compound, RGI-2001, currently in a Phase I/II trial for GvHD associated with hematopoietic stem cell transplantation, and a second product, RGI-3001, in preclinical development for type 1 diabetes. With a pipeline that includes several promising compounds, REGiMMUNE aims to provide innovative treatments that minimize the side effects commonly associated with traditional immunosuppressants.

Drivemode, Inc. is a technology company based in Redwood City, California, that specializes in developing applications designed to enhance the driving experience. Founded in 2014 by former entrepreneurs from Zipcar and Tesla Motors, Drivemode's platform utilizes interaction and feedback technology to provide drivers with personalized navigation suggestions based on their driving patterns, calendar events, and recent communications. The application allows users to manage music and navigation seamlessly, even while making or receiving calls, and facilitates voice-to-text messaging to minimize distractions. Since its Android app launch in 2015, Drivemode has achieved significant growth, garnering over 1 million downloads across 180 countries. The company aims to create a safer and more connected driving environment and collaborates with various stakeholders in the connected car industry to further its mission. Drivemode operates as a subsidiary of Honda R&D Co., Ltd.

FLOSFIA INC. is a Tokyo-based company that focuses on the development of corundum structured Gallium Oxide semiconductor power devices. Founded on March 31, 2011, the company emerged as a spin-off from research conducted at Kyoto University. FLOSFIA specializes in film-formation using mist chemical vapor deposition (CVD) techniques, leveraging the unique physical properties of gallium oxide (Ga2O3) to create high breakdown voltage and high efficiency power devices. The firm is dedicated to advancing low-loss power device technology, contributing to the evolution of semiconductor applications.

Hacarus Inc. is a technology company based in Kyoto, Japan, that specializes in artificial intelligence solutions for the manufacturing and medical sectors. Established in 2014, Hacarus develops products that leverage its proprietary Sparse Modeling technology, which allows for efficient data analysis and decision-making. The company offers several key platforms, including SALUS, which caters to medical and life sciences applications, and COLIGO, a customizable application that supports various implementations in IoT and edge computing. Additionally, Hacarus provides SPECTRO, a tool for enhanced visual inspections, and offers data science consulting services along with an AI Academy for education in AI technologies. By focusing on small data and resource-efficient solutions, Hacarus aims to deliver insights that enable faster and more reliable decision-making compared to traditional deep learning approaches.

Kyoto Drug Discovery and Development Co. Ltd., based in Kyoto, Japan, specializes in the development of innovative therapeutic drugs targeting chronic degenerative eye diseases. The company focuses on creating effective treatments for conditions such as glaucoma, central retinal artery occlusion, retinal pigmentosa, and age-related macular degeneration. By addressing these intractable eye diseases, Kyoto Drug Discovery and Development aims to provide healthcare professionals with advanced options to improve patient outcomes and manage debilitating ocular conditions.

Integral Geometry Science Inc. is a Japanese company founded in 2012, based in Kobe, that specializes in the design and development of advanced measurement devices and software for image data processing. The company focuses on the inverse analysis theory of electromagnetic fields and scattered fields, creating innovative solutions such as a microwave mammography system that effectively addresses the challenges of imaging high-density breast tissue. This technology provides clear images that aid healthcare professionals in accurately distinguishing between cancerous and non-cancerous tissue, significantly reducing the need for painful and radiation-exposing conventional screening methods. Additionally, Integral Geometry Science manufactures nondestructive inspection systems for lithium-ion batteries, further expanding its expertise in measurement systems.

AFI, established on December 23, 2013, in Seoul, Korea, specializes in innovative technology solutions focused on the food and life science industries. The company manufactures and sells products that utilize advanced inspection and monitoring technologies, including electric filter separation systems and rapid microbiological testing. These solutions are designed to address various needs, particularly in monitoring microbial contamination risks, thereby enhancing food safety for its clients. AFI is committed to environmental sustainability while providing effective and efficient technologies in its sector.

Farmship, Inc. is an AgriTech company based in Tokyo, Japan, founded in 2014. It specializes in agricultural food distribution services and develops sustainable agricultural systems through advanced technology. The company focuses on vertical farming, utilizing artificial intelligence and data analytics to optimize growing conditions for crops. This innovative approach allows for increased food production while minimizing resource usage and reducing the environmental impact of agriculture. In addition to its technological advancements, Farmship supports future agriculture through distribution, human resources, and business development initiatives.

Megakaryon Corporation is a medical research company based in Kyoto, Japan, with an additional office in Tokyo. Founded in 2011, the company specializes in developing innovative blood products, specifically platelets and red blood cells, from human induced pluripotent stem (iPS) cell lines. Megakaryon's technology focuses on transfusion medicine, enabling the production of platelets without reliance on traditional blood donations. This approach aims to enhance clinical applications and provide medical practitioners with the ability to manage and maintain patients' platelet counts effectively.

Helpfeel is a technology company focused on human empowerment through knowledge delivery. It specializes in providing tools for Frequently Asked Questions (FAQs), internal knowledge searches, and product recommendations. Its innovative platform allows users to efficiently find answers and connect ideas through collaborative work links. Helpfeel aims to enhance user experiences by streamlining access to information, making it easier for individuals and organizations to navigate their inquiries. Established with a commitment to delivering effective knowledge solutions, the company is positioned to play a significant role in improving information accessibility and user engagement.

iHeart Japan Corporation specializes in developing regenerative medicinal products aimed at treating severe heart failure. Utilizing induced pluripotent stem cell (iPSC) technologies, the company’s primary innovation involves a cardiac regenerative product that allows for the attachment of a cell sheet to the heart. This process is designed to create a vascular network that enhances blood circulation and promotes better therapeutic outcomes. iHeart's mission is to alleviate the need for heart transplants by offering effective alternatives. In addition to its product development, the company also provides healthcare contract and consulting services to assist physicians in restoring cardiac functionality and addressing organ repair, including liver regeneration.

MONEY DESIGN Co., Ltd. is a fintech company based in Tokyo, Japan, founded in 2013. The firm specializes in asset management and investment advisory services, providing automated investment management solutions to its clients. By leveraging technology, MONEY DESIGN aims to simplify the investment process and make financial advice more accessible to a broader audience.